Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anne-Lise, Kamper"'
Autor:
Anders Nissen Bonde, Christian Torp-Pedersen, Anne-Lise Kamper, Gunnar Gislason, Jonas Bjerring Olesen, Laila Staerk, Gregory Y.H. Lip
Publikováno v:
Bonde, A N, Lip, G Y H, Kamper, A-L, Staerk, L, Torp-Pedersen, C, Gislason, G H & Olesen, J B 2017, ' Effect of reduced renal function on time in therapeutic range among anticoagulated atrial fibrillation patients ', Journal of the American College of Cardiology, vol. 69, no. 6, pp. 752-753 . https://doi.org/10.1016/j.jacc.2016.11.031
Atrial fibrillation (AF) patients with creatinine clearance below 30 ml/min have been excluded from randomized controlled trials of non-vitamin K antagonist oral anticoagulants, and the use of warfarin in this population is controversial. Little is k
Autor:
Finn Michael Karlsen, Anne-Lise Kamper
Publikováno v:
Heart Drug. 4:145-150
The renin-angiotensin system (RAS) is activated in several diseases, and angiotensin II mediates a number of putative detrimental effects through activation of the angiotensin II type 1 receptor, while the clinical role of the type 2 receptor has not
Autor:
Ole Torffvit, Paul P. Leyssac, Anne-Lise Kamper, Niels-Henrik Holstein-Rathlou, Per E. Jørgensen, Svend Strandgaard, Steen Seier Poulsen
Publikováno v:
Nephron. 79:167-172
Tamm-Horsfall protein (THP) and epidermal growth factor (EGF) are both synthesized by tubular cells in the distal part of the nephron and excreted with the urine. The present study examines the urinary excretion rates of the two peptides in relation
Publikováno v:
American Journal of Kidney Diseases. 28:822-831
The influence of angiotensin-converting enzyme (ACE) inhibition on renal tubular function in progressive chronic nephropathy was investigated in 69 patients by the lithium clearance (C(Li)) method. Studies were done repeatedly for up to 2 years durin
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41757 (2012)
PLoS ONE
PLoS ONE
Background: Cardiovascular disease (CVD) is highly prevalent in patients with chronic kidney disease (CKD). Inhibition of the renin-angiotensinsystem (RAS) in hypertension causes differential effects on central and brachial blood pressure (BP), which
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 3 (2002)
Combined treatment with an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II (Ang II) receptor blocker (ARB) has been suggested in order to achieve a more complete blockade of the renin-angiotensin-aldosterone system in cardiovascul
Publikováno v:
American Journal of Hypertension. 5:423-430
In order to study the influence of angiotensin converting enzyme (ACE) inhibition on the progression of chronic nephropathy, 70 patients with a median glomerular filtration rate (GFR) of 15 (range, 6 to 54) mL/min/1.73 m2 were randomized in an open s
Autor:
Silje Fismen, Annica Hedberg, Ole Petter Rekvig, Søren Jacobsen, Anne-Lise Kamper, Kristin A. Fenton, Elin Synnøve Mortensen, E Krarup
Publikováno v:
Lupus. 18(7)
Murine and human lupus nephritis are characterized by glomerular deposits of electron-dense structures (EDS). Dominant components of EDS are chromatin fragments and IgG antibodies. Whether glomerular EDS predispose for similar deposits in skin is unk
Autor:
Anne-Lise Kamper
Publikováno v:
Drug Safety. 6:361-370
Angiotensin converting enzyme (ACE) inhibitors are well established in the treatment of hypertension and cardiac failure. Experimental studies in rats have suggested that these agents may protect renal function in chronic nephropathy by a mechanism o
Publikováno v:
European Journal of Nuclear Medicine. 16:85-88
Glomerular filtration rate (GFR) and renal uptake of dimercaptosuccinic acid (DMSA) were measured in 31 patients with progressive chronic nephropathy before and immediately after the start of treatment with angiotensin converting enzyme (ACE) inhibit